Press Releases about Moderna IncFrom Moderna, Inc.
Via AccessWire
Via MarketBeat
From Moderna, Inc.
Via AccessWire
Moderna Announces First Participants Dosed in Phase 3 Study of Seasonal Influenza Vaccine Candidate (mRNA-1010)
June 07, 2022
From Moderna, Inc.
Via AccessWire
Exposures
COVID-19
Moderna and the European Commission Agree on Amendment to COVID-19 Vaccine Supply Agreement
June 02, 2022
From Moderna, Inc.
Via AccessWire
Exposures
COVID-19
Moderna to Present at Upcoming Conferences in June 2022
June 01, 2022
From Moderna, Inc.
Via AccessWire
Topics
Intellectual Property
From Moderna, Inc.
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|